| Not Yet Recruiting | Real-world Cohort Study of Antiretroviral Therapy in HIV Patients With Opportunistic Infections Opportunistic Infections, HIV Related | — | 2026-05-01 |
| Recruiting | Incidence of Liver Disease-Related Outcomes in People With HIV MAFLD, Liver Fibrosis, MASH | — | 2025-07-01 |
| Not Yet Recruiting | Single High-dose of Liposomal Amphotericin B in Combination With B/F/TAF for HIV/AIDS-associated Talaromycosis HIV/AIDS-associated Talaromycosis | N/A | 2025-05-01 |
| Not Yet Recruiting | Safety and Immunogenicity Evaluation of the Recombinant Flagellin Protein Adjuvant COVID - 19 | EARLY_Phase 1 | 2024-12-30 |
| Not Yet Recruiting | Efficacy and Tolerability of DTG Plus 3TC in HIV Infected Adults With Virologically Suppression and TDF Toxici Acquired Immunodeficiency Syndrome | Phase 4 | 2022-08-01 |
| Unknown | Functional Cure Study of Anti-PD-L1 Antibody ASC22 in Combination With Chidamide in HIV-infected Patients With HIV Infections | Phase 2 | 2022-06-29 |
| Unknown | Switching From TDF-based Antiretroviral Therapy Regimens to B/F/TAF in Virally Suppressed Adults With HIV-1 In HIV-1-infection | Phase 4 | 2021-12-08 |
| Unknown | Study of MDW Levels Predicting the Development of Sepsis in Hospitalized HIV-infected Patients and Correlation HIV Infections, Sepsis | — | 2021-12-01 |
| Unknown | Study to Evaluate the Efficacy and Safety of Colchicine Tablets in Patients With COVID-19 Covid19, Colchicine | N/A | 2021-09-06 |
| Completed | Zadaxin and HIV-positive Patients With Immune Reconstitution Disorder HIV-1-infection | EARLY_Phase 1 | 2021-09-01 |
| Unknown | Role of Lymphocyte Subsets and Laboratory Measurements in COVID-19 Disease COVID-19 Disease | — | 2021-04-01 |
| Unknown | Efficacy of 400 mg Efavirenz Versus Standard 600 mg Dose in HIV/TB Co-infected Patients HIV Infections, Tuberculosis | Phase 3 | 2020-11-01 |
| Unknown | TB-LAM in the Diagnosis of TB HIV Infections, Tuberculosis, Non-Tuberculous Mycobacterial Pneumonia | N/A | 2020-10-01 |
| Unknown | Euphorbia Kansui and HIV/AIDS Functional Cure HIV-1-infection | Phase 1 | 2020-08-01 |
| Completed | Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19 Pneumonia, Pneumocystis, Coronavirus, COVID-19 | Phase 3 | 2020-02-06 |
| Unknown | Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19 Coronavirus | — | 2020-02-01 |
| Unknown | Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19 Pneumonia, Pneumocystis, Coronavirus | Phase 3 | 2020-01-30 |
| Unknown | AmB Dose for Cryptococcal Meningitis Cryptococcal Meningitis, HIV Infections | Phase 3 | 2020-01-02 |
| Unknown | NAFLD in HIV-infected Patients HIV-infection/Aids, NAFLD | — | 2019-12-05 |
| Completed | The Drug Interaction Between Albuvirtide (ABT) and Rifampin（RIF） in Healthy Adult Subjects Drug Interaction | Phase 4 | 2019-07-11 |
| Unknown | Rifampicin vs Rifabutin in HIV/AIDS Patients Combined With Tuberculosis Tuberculosis, Pulmonary, AIDS | N/A | 2018-04-15 |
| Completed | Optimization of Antiretroviral Therapy HIV Infections | Phase 4 | 2018-03-05 |
| Completed | Dosing of Tenofovir and Efavirenz in Antiretroviral Therapy HIV Infections | Phase 4 | 2018-03-05 |
| Unknown | An Efficacy and Safety Study of shRNA-modified CD34+ Cells in HIV-infected Patients. HIV Infections, AIDS | Phase 1 | 2018-02-27 |
| Unknown | Gut Microbiota and Immune Recovery HIV-1-infection | — | 2017-12-01 |
| Recruiting | Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tu Non-small Cell Lung Cancer, Small Cell Lung Cancer, Pancreas Cancer | Phase 1 / Phase 2 | 2017-03-01 |
| Unknown | The Efficacy and Safety of R-EPOCH and R-CHOP Regimen for Patients With AIDS Associated CD20+ Diffuse Large B To Evaluate the Efficacy and Safety of R-EPOCH and R-CHOP Regimen for Patients With AIDS Associated CD20+ Diffuse Large B Lymphoma | — | 2017-03-01 |
| Completed | ART Drug Dosage Adjustment in HIV-infected Population HIV Infections | Phase 4 | 2015-04-01 |
| Unknown | Efficacy and Safety of Raltegravir (RAL) in Treatment-experienced HIV-1 Infected Adult Chinese Patients HIV | Phase 4 | 2010-09-01 |
| Unknown | Basic and Clinical Research on Applying Blood Fix to Treat Critical H1N1 Patients Virus Diseases, Respiratory Tract Diseases, Respiratory Tract Infections | Phase 2 | 2009-10-01 |
| Unknown | Efficacy and Safety of MK-0518 in Treatment-Experienced HIV-1 Infected Adult Patients With Hemophilia HIV Infection, Hemophilia A | — | 2009-05-01 |
| Unknown | Acquired Immunodeficiency Syndrome(AIDS) and Tuberculosis(Tb) Co-infection Treatment Strategies Study of China AIDS | N/A | 2009-02-01 |